Caris Life Sciences,�Inc. (CAI)
(Delayed Data from NSDQ)
$32.10 USD
-0.84 (-2.55%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $32.66 +0.56 (1.74%) 5:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Caris Life Sciences,?Inc. has a market cap of $9.26B, which represents its share price of $32.94 multiplied by its outstanding shares number of 281.22M. As a mid-cap company, CAI's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
CAI 32.10 -0.84(-2.55%)
Will CAI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CAI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CAI
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
CAI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for CAI
Is CAI showing upside potential? Crossed Above 50 Day Moving Average shows up after advancing 1.1%
CIBC Launches $450 Million Capital Notes Offering
Fell Below 50 Day Moving Average appears for CAI after 2.54% move
The technical outlook for CAI is unchanged after it falls 0.3% on September 18
Caris Life Sciences: Impressive Growth, But Lock-Up Expiry Looms